SMTL ID : 4ncg.2 (1 other biounit)

Discovery of Doravirine, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.58 Å

Oligo State

hetero-1-1-mer

Ligands

1 x 2KW: 3-chloro-5-({1-[(4-methyl-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)methyl]-2-oxo-4-(trifluoromethyl)-1,2-dihydropyridin-3-yl}oxy)benzonitrile(Non-covalent)

2KW.1: 18 residues within 4Å: Chain A: P.98, L.103, K.104, K.106, V.109, V.111, V.182, Y.184, Y.191, V.192, G.193, P.228, F.230, W.232, L.237, H.238, P.239, Y.321 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.103, A:V.109, A:L.237 Hydrogen bonds: A:K.106, A:K.106 pi-Stacking: A:Y.191, A:W.232

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cote, B. et al., Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses. Bioorg.Med.Chem.Lett. (2014)

Release Date

2014-02-12

Peptides

Reverse transcriptase/ribonuclease H: A
p51 RT: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Reverse transcriptase/ribonuclease H

p51 RT

Related Entries With Identical Sequence